Back to Parallax Volatility Advisers, L.P. Parallax Volatility Advisers, L.P.

MCRB

7 quarters

Position history for Parallax Volatility Advisers, L.P.Parallax Volatility Advisers, L.P.'s holdings in Seres Therapeutics, Inc.

No. Parallax Volatility Advisers exited its MCRB (Seres Therapeutics) position in Q1 2024. Its Q4 2023 13F listed 43,163 shares worth $60,428. Parallax Volatility Advisers first reported MCRB in Q2 2022 and held it in 5 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$343,000

Total Shares Change

-100,000

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%$15.48
0
2023-Q4
Decreased
43,163
-41.3%
$60,4280.0%$28.00
0
2023-Q3
Decreased
73,519
-45.5%
$174,9750.0%$47.60
0
2023-Q2
New
134,901
-
$646,1760.0%$93.80
34
2022-Q4
Exited
0
-100.0%
$00.0%$112.00
0
2022-Q3
Decreased
45,986
-54.0%
$295,0000.0%$122.60
0
2022-Q2
New
100,000
-
$343,0000.0%$63.00
33

Other major holders of MCRB: ARK Investment Management LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used